Jefferies Maintains a 'Conviction-List Buy' on Agilent (A); Valuation Remains Highly Compelling

Jefferies maintains a 'Conviction-List Buy' on Agilent (NYSE: A) price target of $60.00.

Analyst, Jon Wood, said, "Following the recent closing of the Dako acquisition, we publish an extensive examination of the asset's relative competitive position & the broader dynamics of the anatomical pathology (tissue) diagnostics market. We are raising our FY12 & FY13 EPS forecasts to $3.26 (from $3.24) and $3.75 (from $3.50), respectively, to account for anticipated Dako-related contribution."

For an analyst ratings summary and ratings history on Agilent click here. For more ratings news on Agilent click here.

Shares of Agilent closed at $38.91 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cleveland Research Upgrades Dynatrace Inc. (DT) to Buy, 'optimism underlying fundamentals are likely to support upside'
• Needham Reiterates Buy Rating on Amazon.com (AMZN), Raises Estimates
• Jefferies Upgrades Kite Realty Group (KRG) to Buy